174 related articles for article (PubMed ID: 33419057)
1. miR-210 and miR-152 as Biomarkers by Liquid Biopsy in Invasive Ductal Carcinoma.
Lopes BC; Braga CZ; Ventura FV; de Oliveira JG; Kato-Junior EM; Bordin-Junior NA; Zuccari DAPC
J Pers Med; 2021 Jan; 11(1):. PubMed ID: 33419057
[TBL] [Abstract][Full Text] [Related]
2. Association study of miR-22 and miR-335 expression levels and G2 assay related inherent radiosensitivity in peripheral blood of ductal carcinoma breast cancer patients.
Bakhtari N; Mozdarani H; Salimi M; Omranipour R
Neoplasma; 2021 Jan; 68(1):190-199. PubMed ID: 32853021
[TBL] [Abstract][Full Text] [Related]
3. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.
Erbes T; Hirschfeld M; Rücker G; Jaeger M; Boas J; Iborra S; Mayer S; Gitsch G; Stickeler E
BMC Cancer; 2015 Mar; 15():193. PubMed ID: 25886191
[TBL] [Abstract][Full Text] [Related]
5. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway.
Sabry D; El-Deek SEM; Maher M; El-Baz MAH; El-Bader HM; Amer E; Hassan EA; Fathy W; El-Deek HEM
Mol Cell Biochem; 2019 Apr; 454(1-2):177-189. PubMed ID: 30357530
[TBL] [Abstract][Full Text] [Related]
6. A circulating miR-19b-based model in diagnosis of human breast cancer.
Zhao Q; Shen L; Lü J; Xie H; Li D; Shang Y; Huang L; Meng L; An X; Zhou J; Han J; Yu Z
Front Mol Biosci; 2022; 9():980841. PubMed ID: 36188229
[No Abstract] [Full Text] [Related]
7. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
[TBL] [Abstract][Full Text] [Related]
8. Decreased serum miR-181a is a potential new tool for breast cancer screening.
Guo LJ; Zhang QY
Int J Mol Med; 2012 Sep; 30(3):680-6. PubMed ID: 22692639
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNAs, miR-92a, miR-100 and miR-143, as non-invasive biomarkers for bladder cancer diagnosis.
Motawi TK; Rizk SM; Ibrahim TM; Ibrahim IA
Cell Biochem Funct; 2016 Apr; 34(3):142-8. PubMed ID: 26916216
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Expressed MicroRNAs as Prospective Biomarkers for Detection of Breast Cancer.
Mohamed AA; Allam AE; Aref AM; Mahmoud MO; Eldesoky NA; Fawazy N; Sakr Y; Sobeih ME; Albogami S; Fayad E; Althobaiti F; Jafri I; Alsharif G; El-Sayed M; Abdelgeliel AS; Abdel Aziz RS
Diagnostics (Basel); 2022 Mar; 12(4):. PubMed ID: 35453838
[TBL] [Abstract][Full Text] [Related]
11. hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer.
Camps C; Buffa FM; Colella S; Moore J; Sotiriou C; Sheldon H; Harris AL; Gleadle JM; Ragoussis J
Clin Cancer Res; 2008 Mar; 14(5):1340-8. PubMed ID: 18316553
[TBL] [Abstract][Full Text] [Related]
12. A five-miRNA panel in plasma was identified for breast cancer diagnosis.
Li M; Zou X; Xia T; Wang T; Liu P; Zhou X; Wang S; Zhu W
Cancer Med; 2019 Nov; 8(16):7006-7017. PubMed ID: 31568692
[TBL] [Abstract][Full Text] [Related]
13. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients.
Kassem NM; Makar WS; Kassem HA; Talima S; Tarek M; Hesham H; El-Desouky MA
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2749-2755. PubMed ID: 31554373
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer.
Bertoli G; Cava C; Castiglioni I
Theranostics; 2015; 5(10):1122-43. PubMed ID: 26199650
[TBL] [Abstract][Full Text] [Related]
15. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
[TBL] [Abstract][Full Text] [Related]
16. Discovery of potential serum and urine-based microRNA as minimally-invasive biomarkers for breast and gynecological cancer.
Ritter A; Hirschfeld M; Berner K; Jaeger M; Grundner-Culemann F; Schlosser P; Asberger J; Weiss D; Noethling C; Mayer S; Erbes T
Cancer Biomark; 2020; 27(2):225-242. PubMed ID: 32083575
[TBL] [Abstract][Full Text] [Related]
17. Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer.
Du M; Shi D; Yuan L; Li P; Chu H; Qin C; Yin C; Zhang Z; Wang M
Sci Rep; 2015 May; 5():10437. PubMed ID: 26014226
[TBL] [Abstract][Full Text] [Related]
18. Serum microRNA as potential biomarker to detect breast atypical hyperplasia and early-stage breast cancer.
An X; Quan H; Lv J; Meng L; Wang C; Yu Z; Han J
Future Oncol; 2018 Dec; 14(30):3145-3161. PubMed ID: 30220214
[TBL] [Abstract][Full Text] [Related]
19. Expression level of miR-155, miR-15a and miR-19a in peripheral blood of ductal carcinoma breast cancer patients: Possible bioindicators for cellular inherent radiosensitivity.
Rajabi F; Mozdarani H
Exp Mol Pathol; 2022 Jun; 126():104758. PubMed ID: 35337805
[TBL] [Abstract][Full Text] [Related]
20. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
